Venous reflux disease treatment developer Venclose announced that it closed a Series C funding round totaling $27 million. Venclose develops the next-generation Venclose RF ablation system designed to close damaged veins and restore healthy blood flow in patients with venous reflux disease. The San Jose, Calif.–based company said that, after securing the $27 million, it […]
Penumbra appoints new chief financial and accounting officers
Penumbra (NYSE:PEN) recently announced that it appointed Maggie Yuen as chief financial officer and Lambert Shiu as chief accounting officer, effective Dec. 2. Yuen replaces president and chief financial officer Sri Kosaraju. Kosaraju will continue to serve as president following the appointment. Prior to joining Penumbra, Yuen held a number of leadership roles in the manufacturing, […]
Merit Medical lands breakthrough designation for dialysis stent graft system
Merit Medical (NSDQ:MMSI) announced last week that it has been granted FDA breakthrough device designation for its Wrapsody endovascular stent graft system. Wrapsody is a flexible, self-expanding endoprosthesis designed for hemodialysis patients. Merit said it will seek indication to treat stenosis within the central veins of the outflow circuit of an arteriovenous fistula (AVF) up […]
Stent makers point to quality-of-life findings by massive federal study
The giant federal study that found the use of stents in stable heart-disease patients is no better than drugs to treat clogged arteries reached another, less-hyped conclusion. Manufacturers of stents for percutaneous coronary intervention (PCI) note that the Ischemia study also concluded that patients who undergo a stenting procedure have a better quality of life. They suffer […]
Study: Stents no better than drugs for stable heart disease
This article has been updated with stock market results and comments from Medtronic. A major new study has concluded that the use of stents in stable heart disease patients is no better than drugs to treat clogged arteries. Results of the Ischemia study were released at the American Heart Association annual meeting in Philadelphia on Saturday. The […]
Okami Medical wins FDA clearance for vascular occlusion system
Okami Medical yesterday said it won FDA 510(k) clearance for its LOBO Vascular Occlusion System. The Low-Profile Braided Occluder (LOBO) system helps patients and physicians with the occlusion of peripheral blood vessels. The system uses HDBraid technology to give physicians a minimally invasive platform for rapid and focal occlusion of a wide range of arterial […]
Japan approves Medtronic’s Valiant Navion stent graft
Medtronic (NYSE:MDT) said today that it received Shonin approval and launched its Valiant Navion thoracic stent graft system in Japan for the minimally invasive repair of thoracic descending aortic aneurysms and Type B aortic dissections. The Fridley, Minn.-based company said it is the third major geographical launch of the Valiant Navion system after it won FDA […]
Hancock Jaffe touts 6-month results for VenoValve
Hancock Jaffe Laboratories (NSDQ:HJLI) said yesterday that six-month data from its in-human VenoValve study showed that the first five patients observed displayed improvements in all study endpoints. Principal investigator Dr. Jorge Hernando Ulloa reported that the patients showed 10% improvement in reflux, 2% improvement in disease manifestations (VCSS scores) and 13% improvements in pain (VAS scores) […]
Corindus Vascular Robotics shareholders OK $1B Siemens Healthineers takeover
Corindus Vascular Robotics (NYSE:CVRS) said today that its stockholders approved the adoption of a $1.1 billion merger with with Siemens (NYSE:SI). Waltham, Mass.-based Corindus said the transaction is slated to close Oct. 29, after which Corindus will be delisted from the New York Stock Exchange, according to a news release. Corindus stockholders are set to receive $4.28 per […]
Shape Memory Medical wins CE Mark for Trellix embolic coil
Shape Memory Medical said today that it won CE Mark approval in the European Union for its Trellix embolic coil for treating vascular abnormalities in brain and peripheral vasculature. The device is made using the Santa Clara, Calif.-based company’s shape memory polymer, a porous, polymeric material capable of changing from a smaller, catheter-deliverable shape to […]
Admedus deals biologic patch business to LeMaitre Vascular for $24m
Admedus (ASX:AHZ) dealt its biologic patch business to LeMaitre Vascular (NSDQ:LMAT) in a deal worth up to $24.6 million to focus on the transcatheter aortic valve replacement market. The A$36.2 million buyout of the CardioCel and VascuCel patches called for LeMaitre to put up $14.2 million up front, with another $1.4 million due in a pair […]
- 1
- 2
- 3
- …
- 74
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube